Breaking News
2 hours ago
Pharma Now Editorial Team

Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Supreme Court temporarily restores mifepristone access via telehealth and mail, reopening REMS compliance questions for manufacturers and pharmacies.
Pharma Now Editorial Team

Aurobindo Pharma confirms CEO resignation at API subsidiary Apitoria Pharma, with successor search now underway.
Pharma Now Editorial Team

UCB acquires Candid Therapeutics, triggering technology transfer, GMP alignment, and regulatory filing reviews across both organizations.
Pharma Now Editorial Team

FDA data shows GDUFA Type II API DMF payments at 147 through May FY2026, tracking below recent full-year totals and signaling potential generics pipeline shifts.
Pharma Now Editorial Team
